Baroma ACO and Walgreens Collaborate to Reduce Readmissions and Drive
MIAMI, Oct. 22, 2013 (GLOBE NEWSWIRE) -- Baroma, Inc. (OTCMarkets:BRMA) today
announced a strategic relationship with Walgreens (NYSE:WAG) (Nasdaq:WAG) that
will bring pharmacists and hospital staff together to help reduce
re-admissions and increase medication adherence for Baroma's accountable care
Baroma has implemented Walgreens WellTransitions program, a collaborative
transition of care program that provides ongoing follow-up and patient support
during and after discharge from the hospital, to help achieve its goals for
re-admissions and medication adherence, two important criteria outlined under
the shared savings initiative with The Centers for Medicare and Medicaid
WellTransitions, launched by Walgreens in 2012, utilizes features such as
real-time patient readmission information, root cause analysis and more as
part of a multi-step process that spans the discharge period. The program has
already proven instrumental in helping hospitals recognize the "triple aim" of
greater patient satisfaction, better health outcomes and lower costs.
As an Accountable Care Organization (ACO), Baroma has chosen to further
develop Walgreens WellTransitions as an ACO-specific tool, with the Walgreens
pharmacy team working in collaboration with Baroma Care Navigators and
participating physicians to reduce preventable hospital readmission by
improving medication adherence.
"The health information landscape is fragmented, with individual groups or
facilities often knowing only what they have prescribed or what their patients
have discussed with them. Now, when a patient is discharged, we can inform our
physicians of their patient's medication history. So, as the primary care
physician, they can make more informed decisions and can better educate their
patients on how they should take their medications. This access to information
will help reduce hospital admission caused by medication mismanagement or
non-adherence," says Marisela Rodriguez, Baroma's COO.
Learn more: www.baromahc.com.
Baroma, Inc. is a healthcare management company tasked with helping solve
today's challenging healthcare puzzle.Having applied its capabilities across
unique markets globally, Baroma, Inc. has developed the scalability and
resources necessary to overcome the most important challenges in today's
evolving healthcare environment. Its subsidiaries, doing business as Baroma
Health Partners™, are among the first new Accountable Care Organizations
developed as an alternative to the fragmented, high cost healthcare system
nationally. Baroma Healthcare International, LLC. is the first Medicare Shared
Savings Program ACO in Miami-Dade County Florida – traditionally one of the
costliest, per-capita, counties in the country. Baroma, Inc. is determined to
be the catalyst for change to a better system of healthcare delivery by
enriching the health of our communities though the coordination, integration
and accountability of care.
Statements in this press release relating to plans, strategies, economic
performance and trends, projections of results of specific activities or
investments, and other statements that are not descriptions of historical
facts may be forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking
information is inherently subject to risks and uncertainties, and actual
results could differ materially from those currently anticipated due to a
number of factors, which include, but are not limited to, risk factors
inherent in doing business. Forward-looking statements may be identified by
terms such as "may," "will," "should," "could," "expects," "plans," "intends,"
"anticipates," "believes," "estimates," "predicts," "forecasts," "potential,"
or "continue," or similar terms or the negative of these terms. Although we
believe that the expectations reflected in the forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity,
performance or achievements. The Company has no obligation to update these
CONTACT: Investor information:
(888) 315-4490, 115
Press spacebar to pause and continue. Press esc to stop.